Skip to content

Impact of prophylactic continuous positive airway pressure in the delivery room (DR-CPAP) on neonates <1500g in a low-resource setting: A feasibility trial

Impact of prophylactic continuous positive airway pressure in the delivery room (DR-CPAP) on neonates <1500g in a low-resource setting: A feasibility trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202208462613789
Enrollment
100
Registered
2022-08-08
Start date
2022-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paediatrics

Interventions

Delivery Room Continuous Positive Airways Pressure DRCPAP
standard bCPAP SbCPAP

Sponsors

Mbale Clinical Research Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Liveborn infants born weighing <1500g • Infants born in Mbale RRH • Mother who can understand English, Luganda, Ateso or Lumasaba • Mother is willing and able to give informed, written consent for participation of her infant in the study. • Mother aged 18 years or above, or those under 18 so long as emancipated.

Exclusion criteria

Exclusion criteria: • Infants born weighing =1500g • Stillborn infants • Infants born outside of Mbale RRH • Mother who can not understand English, Luganda, Ateso or Lumasaba • Maternal death • Infants with major congenital abnormality e.g. gastroschisis, cyanotic heart disease

Design outcomes

Primary

MeasureTime frame
Neonatal mortality - death before 28 days of age

Secondary

MeasureTime frame
• Total time on CPAP (days) • High grade (grades III and IV) intraventricular haemorrhage on cranial ultrasound before 7 days of age • Haemodynamically significant patent ductus arteriosus on echocardiogram at 72 hours of age • Significant nasal septal erosions (Superfical erosion or septal necrosis) daily until CPAP is weaned • Pneumothorax on lung ultrasound • Bronchopulmonary dysplasia – need for supplemental oxygen for =28 days • Length of hospital stay (days)

Countries

Uganda

Contacts

Public ContactMichael Egesa

Operations Officer

mpegesa_1@yahoo.com+256772633190

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026